Craig Schilling

Sr. Director, Respiratory & Immunology Portfolio Contract Strategy at AstraZeneca

Craig Schilling, Pharm.D., possesses extensive experience in the pharmaceutical and healthcare sectors, holding senior leadership roles at AstraZeneca, where responsibilities included Sr. Director positions in Respiratory & Immunology Portfolio Contract Strategy, Value Strategy & Evidence, and Field Health Outcomes. Previously, Craig served as Board Chairman for the American Lung Association in Minnesota and as Vice President of Patient Programs at Optum - Patient Insights. Additional experience includes an Executive Director role in Medical Affairs - Managed Markets at Novartis Pharmaceuticals and Sr. Director positions at Pharmacia Corporation, focusing on Medical Marketing and Advocacy as well as national operations. Craig holds a Pharm.D. and a Post-Doctorate Fellowship in Clinical Pediatric Research, both from the University of Minnesota.

Links

Previous companies

Novartis logo
UnitedHealth Group logo

Timeline

  • Sr. Director, Respiratory & Immunology Portfolio Contract Strategy

    June, 2022 - present

  • Sr. Director, Value Strategy & Evidence

    January, 2021

  • Sr. Director, Field Health Outcomes

    September, 2019